Latest Copper News

Zenith Minerals has secured final Turkish regulatory approval for the sale of its Kavaklitepe Gold Project stake, unlocking approximately A$830,000 in cash proceeds. This milestone paves the way for the company to accelerate exploration at its core Australian gold assets.

Mount Hope Mining has received regulatory approval to commence its maiden drilling program at the Mt Hope Project, targeting three high-potential gold prospects in New South Wales.

S2 Resources reports a notable gold-arsenic-antimony anomaly from reconnaissance drilling at Fosterville, setting the stage for targeted follow-up exploration. Meanwhile, drilling at Glenlogan advances with assays pending, and Warraweena prepares for initial drill testing.

Talisman Mining ramps up exploration in New South Wales with new gold targets and advances its Mabel Creek IOCG project in South Australia, supported by strong financials and ongoing drilling programs.

Freehill Mining is progressing towards restarting operations at its Yerbas Buenas magnetite mine with a targeted six-month timeline, while exploration at the adjoining El Dorado project reveals promising magnetite and copper-gold potential.

New World Resources has acknowledged an increased takeover offer from Kinterra, triggering a matching rights process with Central Asia Metals. The board signals potential for a superior proposal amid a competitive bidding landscape.

CuFe Ltd has enhanced the confidence level of its Orlando deposit resource at Tennant Creek, increasing the Indicated classification from 42% to 56% following a rigorous QAQC review. This upgrade supports the imminent release of the Orlando Scoping Study.

Pivotal Metals has enhanced its Midrim Field exploration announcement by adding detailed assay data and launching an AI-driven program targeting high-grade copper-nickel-PGM deposits in Canada’s Belleterre-Angliers Greenstone Belt. The company aims to leverage historic drilling successes and modern geophysics to unlock new discoveries.

Australian Rare Earths Limited (ASX, AR3) reports strong progress in rare earth recovery and uranium exploration, alongside a successful capital raise and strategic U.S. government registrations.

Clarity Pharmaceuticals has successfully completed recruitment for its pivotal Co-PSMA Phase II trial, testing its novel Cu-SAR-bisPSMA diagnostic against the current standard in detecting prostate cancer recurrence. This milestone advances their mission to improve early detection and treatment outcomes for men with low PSA levels.

New World Resources has unanimously recommended Central Asia Metals’ improved takeover bid, which offers a higher price and unconditional terms, setting the stage for a decisive shareholder vote.

Locksley Resources has confirmed multiple new mineralised trends at its Mojave Critical Minerals Project in California, setting the stage for an expanded drilling campaign in Q3 2025. The company’s detailed structural mapping and 3D geological modelling have refined exploration targets for antimony and rare earth elements, aligning with growing US strategic interests in domestic critical minerals.